ISLAMABD, 05 Mar (Online): After studying thousands of people\u2019s symptoms post-COVID-19, researchers have found that getting vaccinated could potentially reduce the risk of long COVID. <\/p>\n
The new study \u2013 which looked at patients 3 months after their COVID-19 infections across pre-Delta, Delta, and Omicron variants \u2013 at first saw that long COVID symptoms were more common in the pre-Delta period than in the Delta and Omicron periods. But these differences across variants became less important when researchers adjusted for vaccination status, suggesting that the vaccine could play a key role in lessening the risk of long COVID and making its symptoms less severe. <\/p>\n
Another important finding of the study, from researchers at Chicago\u2019s Rush University Medical Center and the University of California San Francisco and published in the journal Clinical Infectious Diseases, was the sheer number of people post-COVID-19 who reported severe fatigue. <\/p>\n
\u201cMild fatigue is much different than severe, life-impacting fatigue,\u201d lead author Michael Gottlieb, MD, said at a media briefing Wednesday. \u201cOne in eight affected with COVID had severe, prolonged fatigue at 3 months. \u2026
\nThat speaks to the impact we\u2019re seeing as a society.\u201d <\/p>\n
The study included 2,402 COVID-positive and 821 COVID-negative people, with 463 falling into the pre-Delta category, 1,198 during Delta, and 741 during Omicron. <\/p>\n
The authors did not weigh how severe the patients\u2019 initial COVID infections were versus their prolonged symptoms, but Gottlieb told reporters that the group is currently working on supplemental survey research to see if there are any parallels between the two. <\/p>\n
Gottlieb said the research team is continuing to follow patients beyond the 3-month mark, to see what the paths of their symptoms look like. Some early data, he said, shows patients\u2019 symptoms going in both directions: Some people who have minimal symptoms at 3 months might convert to severe symptoms at 6 months, and others with severe symptoms at 3 months might be better at 6 months. <\/p>\n
All of these lingering questions, including how reinfection plays into long COVID, will be the focus of future research for Gottlieb\u2019s team. <\/p>\n
\u201cWe need to understand long COVID better, and we need to define it better,\u201d Gottlieb said. \u201cLong COVID isn\u2019t a singular concept; there are different phenotypes and versions of it. As researchers, public health leaders, and as a society, we need to better understand what people are going through.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"
ISLAMABD, 05 Mar (Online): After studying thousands of people\u2019s symptoms post-COVID-19, researchers have found that getting vaccinated could potentially reduce the risk of long COVID. The new study \u2013 which looked at patients 3 months after their COVID-19 infections across pre-Delta, Delta, and Omicron variants […]<\/p>\n
\n","protected":false},"author":2,"featured_media":71003,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9821],"tags":[],"class_list":["post-71002","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-health-news"],"yoast_head":"\n